Apoyo Inmunológico

KPV

Price range: $94.00 through $146.00

Per vial
$9.40
10 vials per pack
Suggested retail
$28.20
3× markup · per vial
Envío gratuito en pedidos superiores a $2,000
$300 store credit on any independent COA · results don't matter
  • Garantía de entrega Reenvío gratuito si no llega
  • Pureza ≥99 % Producción directa del fabricante
  • Certificados de análisis independientes Ver certificados de análisis de este producto →
  • Garantía de crédito en tienda Envía cualquier resultado de COA y obtén crédito en la tienda

KPV - Lysine-Proline-Valine Anti-Inflammatory Tripeptide

KPV is a three-amino-acid peptide - Lysine-Proline-Valine - that forms the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). While the full alpha-MSH peptide is best known for pigmentation signaling, the KPV fragment retains most of alpha-MSH’s anti-inflammatory activity while losing its melanocortin-receptor agonism. That is why researchers use KPV on its own - it isolates the anti-inflammatory arm of alpha-MSH biology without the pigmentation or appetite effects.


Why the Tripeptide Form Matters

KPV is small enough to be absorbed intact through the PepT1 transporter in the intestinal epithelium, which is the reason oral-delivery studies exist for it (most peptides this short would simply be degraded). Once inside the cell, it is cited in literature as downregulating NF-kappaB signaling and suppressing pro-inflammatory cytokine release. It is one of the few peptides with a published profile covering injected, oral, and topical routes.

Itinerario En pocas palabras, esto es lo que hace
PepT1 transporter (gut) Carries KPV intact through the intestinal wall - the reason oral studies exist
NF-kappaB signaling Downregulated; cited in most KPV anti-inflammatory literature
Mast cells and macrophages Reduced pro-inflammatory cytokine release in published in-vitro work

KPV vs BPC-157

These two show up together in a lot of gut-repair literature, so the distinction matters.

Péptido Primary pathway Most-studied application
KPV Anti-inflammatory (NF-kappaB suppression) Colitis models, skin inflammation, mast-cell regulation
BPC-157 Angiogenesis and tissue repair (VEGF, nitric-oxide) GI mucosa, tendon, ligament

Researchers pair them in some study designs (KPV + BPC-157 capsules appear in the published literature) because the mechanisms are non-overlapping - one suppresses inflammation, the other builds structural repair.


Aplicaciones de investigación

KPV is used in studies examining:

  • Colitis and intestinal-inflammation models (including the PepT1 oral-absorption pathway)
  • Mast-cell and macrophage anti-inflammatory signaling
  • Skin-inflammation models (transdermal and topical delivery)
  • NF-kappaB-mediated cytokine suppression
  • Comparative repair-peptide study designs (KPV + BPC-157)
  • Delivery-route comparisons (injected, oral, transdermal)

Especificaciones

Formato Polvo liofilizado
Pureza ≥99%
Alias Lysine-Proline-Valine, Lys-Pro-Val, alpha-MSH (11-13) fragment
Tamaños disponibles 5 mg · 10 mg
Almacenamiento 2-8 °C sin abrir; estable durante más de 12 meses
Uso Research purposes only - not for human use

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for KPV are documented in the published peer-reviewed literature and standard peptide-chemistry references.


Reference Literature

Published clinical and preclinical KPV literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.


Common Questions About KPV Research

What does KPV do in research?

It is most commonly studied as an anti-inflammatory signaling peptide. In published in-vitro and animal work it downregulates NF-kappaB, reduces pro-inflammatory cytokine release from mast cells and macrophages, and is absorbed intact through the PepT1 gut transporter - which is why it appears in colitis and intestinal-inflammation models.

How is KPV different from BPC-157?

They act through different pathways. KPV is an anti-inflammatory tripeptide that suppresses NF-kappaB signaling. BPC-157 is a 15-amino-acid peptide most closely associated with angiogenesis and structural tissue repair. The two are sometimes paired in gut-repair research designs because the mechanisms do not overlap.

Can KPV be taken orally in research?

Yes - KPV is one of the few peptides with published oral-absorption data, because the PepT1 transporter carries the tripeptide across the intestinal wall intact. Injected and transdermal delivery are also represented in the literature. Route selection in a study depends on the endpoint being measured.

Is KPV FDA approved?

No. KPV is not approved by the FDA for any human use. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is KPV stored?

Los viales sin abrir se conservan a una temperatura de entre 2 y 8 °C y se mantienen estables durante más de 12 meses. Una vez reconstituida con agua bacteriostática, la solución se conserva a una temperatura de entre 2 y 8 °C y debe utilizarse en un plazo de 28 a 30 días.


Garantía de pureza

Cada lote tiene una pureza ≥99 %. Envíanos un certificado de análisis (COA) de cualquier análisis independiente y te daremos un vale de compra, independientemente de lo que indique.